UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 818

Sortiert nach

Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity

Tumor biology, 2015-12, Vol.36 (12), p.9499-9510

2015

Link zum Volltext

Verfügbarkeit prüfen

Salidroside could enhance the cytotoxic effect of L‑OHP on colorectal cancer cells

Molecular medicine reports, 2018-01, Vol.17 (1), p.51-58

2018

Link zum Volltext

Verfügbarkeit prüfen

Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy

Oncology reports, 2016-12, Vol.36 (6), p.3682-3690

2016

Link zum Volltext

Verfügbarkeit prüfen

Hypersensitivity reactions related to oxaliplatin (OHP)

British journal of cancer, 2003-08, Vol.89 (3), p.477-481

2003

Link zum Volltext

Verfügbarkeit prüfen

Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway

Experimental cell research, 2020-04, Vol.389 (1), p.111856-111856, Article 111856

2020

Link zum Volltext

Verfügbarkeit prüfen

Role of HOXB7 in promoting gastric cancer progression and oxaliplatin (L-OHP) resistance

International journal of clinical and experimental pathology, 2020-01, Vol.13 (6), p.1381-1389

2020

Link zum Volltext

Verfügbarkeit prüfen

Human rpL3 plays a crucial role in cell response to nucleolar stress induced by 5-FU and L-OHP

Oncotarget, 2014-11, Vol.5 (22), p.11737-11751

2014

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab improves splenomegaly and decreases production of hyaluronic acid after L-OHP based chemotherapy

Anticancer research, 2014-04, Vol.34 (4), p.1953-1958

2014

Link zum Volltext

Verfügbarkeit prüfen

Cell Cycle Arrest and Apoptosis Induced by Oxaliplatin (L-OHP) on Four Human Cancer Cell Lines

Anticancer research, 2006-05, Vol.26 (3A), p.2093-2099

2006

Link zum Volltext

Verfügbarkeit prüfen

Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP

Anti-cancer drugs, 2007-07, Vol.18 (6), p.633-639

2007

Link zum Volltext

Verfügbarkeit prüfen

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

Annals of oncology, 1996-01, Vol.7 (1), p.95-98

1996

Link zum Volltext

Verfügbarkeit prüfen

Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial

Annals of oncology, 2004-08, Vol.15 (8), p.1204-1209

2004

Link zum Volltext

Verfügbarkeit prüfen

Ozone attenuates chemotherapy-induced peripheral neuropathy via upregulating the AMPK-SOCS3 axis

Journal of cancer research and therapeutics, 2023-08, Vol.19 (4), p.1031-1039

2023

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer

Frontiers in oncology, 2022-10, Vol.12, p.911160-911160

2022

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin (L-OHP): a new reality in colorectal cancer

British journal of cancer, 1998-06, Vol.77 (S4), p.1-3

Bleiberg, H

1998

Link zum Volltext

Verfügbarkeit prüfen

The role of autophagy in the treatment of colon cancer by chlorin e6 photodynamic therapy combined with oxaliplatin

Photodiagnosis and photodynamic therapy, 2022-12, Vol.40, p.103082-103082, Article 103082

2022

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin's lymphoma patients

Annals of oncology, 1999-03, Vol.10 (3), p.351-354

1999

Link zum Volltext

Verfügbarkeit prüfen

CircAGFG1 absence decreases PKM2 expression to enhance oxaliplatin sensitivity in colorectal cancer in a miR-7-5p-dependent manner

Journal of chemotherapy (Florence), 2024-05, Vol.36 (3), p.208-14

2024

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Oxaliplatin-induced Chronic Neuropathy and Anticancer Efficacy Through Pharmacokinetic and Toxicodynamic Evaluation of a Rat Model of Colorectal Cancer

Anticancer research, 2019-08, Vol.39 (8), p.4207-4213

2019

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer

European journal of cancer (1990), 1997-08, Vol.33 (9), p.1400-1406

1997

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the Effectiveness of Human Papillomavirus Educational Intervention among Oral Health Professionals

Journal of cancer education, 2019-10, Vol.34 (5), p.890-896

2019

Link zum Volltext

Verfügbarkeit prüfen

Changes in upper extremity function, ADL, and HRQoL in colorectal cancer patients after the first chemotherapy cycle with oxaliplatin: a prospective single-center observational study

Supportive care in cancer, 2018-07, Vol.26 (7), p.2397-2405

2018

Link zum Volltext

Verfügbarkeit prüfen

Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell

OncoTargets and therapy, 2018-01, Vol.11, p.809-821

2018

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin (L-OHP) treatment of human myeloma cells induces in vitro growth inhibition and apoptotic cell death

European journal of cancer (1990), 2002-05, Vol.38 (8), p.1141-1147

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 818

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(745)
Mit Volltextzugriff
(778)

Publikationsform

Artikel
(817)
Buchkapitel
(1)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(787)
Life Sciences & Biomedicine
(780)
Humans
(561)
Chemotherapy
(392)
Colorectal Cancer
(318)
Female
(317)
Male
(290)
Oxaliplatin
(282)
Middle Aged
(266)
Aged
(250)
Tumors
(228)
Adult
(213)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(207)
Colorectal Neoplasms - Drug Therapy
(206)
Biological And Medical Sciences
(202)
Medical Sciences
(201)
Cancer Research
(196)
Cancer Therapies
(181)
Organoplatinum Compounds - Administration & Dosage
(176)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Chemotherapy And Pharmacology
(40)
British Journal Of Cancer
(37)
Oncology
(35)
International Journal Of Clinical Oncology
(32)
Oncology Letters
(31)
Cancers
(28)
Annals Of Oncology
(26)
Oncology Reports
(26)
Cancer Science
(19)
Anti-Cancer Drugs
(18)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity

Salidroside could enhance the cytotoxic effect of L‑OHP on colorectal cancer cells

Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy

Hypersensitivity reactions related to oxaliplatin (OHP)

Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway

Role of HOXB7 in promoting gastric cancer progression and oxaliplatin (L-OHP) resistance

Human rpL3 plays a crucial role in cell response to nucleolar stress induced by 5-FU and L-OHP

Bevacizumab improves splenomegaly and decreases production of hyaluronic acid after L-OHP based chemotherapy

Cell Cycle Arrest and Apoptosis Induced by Oxaliplatin (L-OHP) on Four Human Cancer Cell Lines

Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial

Ozone attenuates chemotherapy-induced peripheral neuropathy via upregulating the AMPK-SOCS3 axis

Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer

Oxaliplatin (L-OHP): a new reality in colorectal cancer

The role of autophagy in the treatment of colon cancer by chlorin e6 photodynamic therapy combined with oxaliplatin

Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin's lymphoma patients

CircAGFG1 absence decreases PKM2 expression to enhance oxaliplatin sensitivity in colorectal cancer in a miR-7-5p-dependent manner

Assessment of Oxaliplatin-induced Chronic Neuropathy and Anticancer Efficacy Through Pharmacokinetic and Toxicodynamic Evaluation of a Rat Model of Colorectal Cancer

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer

Evaluating the Effectiveness of Human Papillomavirus Educational Intervention among Oral Health Professionals

Changes in upper extremity function, ADL, and HRQoL in colorectal cancer patients after the first chemotherapy cycle with oxaliplatin: a prospective single-center observational study

Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell

S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuvant Chemotherapy in Patients With High-risk Stage III Colon Cancer (ACTS-CC 02): A Randomized, Open-label, Multicenter, Phase III Superiority Trial

Oxaliplatin (L-OHP) treatment of human myeloma cells induces in vitro growth inhibition and apoptotic cell death

Aktive Filter

Suchergebnisse filtern